Difference between revisions of "Section 4: COVID-19: ICU delirium management:potential problems and solutions (from DOI: 10.1186/s13054-020-02882-x) (Q10754)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: named entity (P78): Coronaviridae (species) (Q10871), #quickstatements; #temporary_batch_1593005539138)
(‎Created claim: named entity (P78): gamma-Aminobutyric Acid (chemical - MeSH descriptor) (Q11059), #quickstatements; #temporary_batch_1593005539138)
Property / named entity
 +
Property / named entity: gamma-Aminobutyric Acid (chemical - MeSH descriptor) / rank
 +
Normal rank

Revision as of 13:32, 24 June 2020

Publication: "COVID-19: ICU delirium management during SARS-CoV-2 pandemic"published as Crit Care; 2020 04 28 ; 24 (1) 176; DOI: 10.1186/s13054-020-02882-x
Language Label Description Also known as
English
Section 4: COVID-19: ICU delirium management:potential problems and solutions (from DOI: 10.1186/s13054-020-02882-x)
Publication: "COVID-19: ICU delirium management during SARS-CoV-2 pandemic"published as Crit Care; 2020 04 28 ; 24 (1) 176; DOI: 10.1186/s13054-020-02882-x

    Statements

    0 references